Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Boehringer Ingelheim
Queensland Health
Johnson and Johnson

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,047,398

« Back to Dashboard

Summary for Patent: 5,047,398

Title: DDAVP antidiuretic and method therefor
Abstract:There is disclosed, in one aspect, an antidiuretic composition in oral dosage form for humans. This composition comprises an antidiuretically effective amount of 1-deamino-8-D-arginine vasopressin (DDAVP) and a pharmaceutically acceptable carrier. The composition is capable of dissolving and being absorbed in the gastrointestinal tract of a human. The composition isused in tablet, capsule, or other generally accepted oral dosage form and generally from about 50 to about 200 micrograms of DDAVP is used per unit dosage In another aspect, there is disclosed a method for treating diabetes insipidus. This method comprises orally administering an antidiuretically effective amount of DDAVP to a human. The DDAVP is substantially dissolved and absorbed in the gastrointestinal tract of the person so treated.
Inventor(s): Hagstam; Helmer (Malmo, SE), Vilhardt; Hans (Espergarde, DK)
Assignee: Ferring B.V. (Haarlen, NL)
Application Number:06/809,937
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,047,398

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden8306367Nov 18, 1983

International Patent Family for Patent: 5,047,398

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany3482028► Subscribe
Denmark546284► Subscribe
Denmark168515► Subscribe
European Patent Office0163723► Subscribe
Finland844540► Subscribe
Hong Kong76091► Subscribe
Ireland842951► Subscribe
Ireland57989► Subscribe
Israel73523► Subscribe
Canada1232839► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Cantor Fitzgerald
Farmers Insurance
Express Scripts
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: